246
Views
10
CrossRef citations to date
0
Altmetric
Letter

Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia

, , , &
Pages 1336-1339 | Received 06 Aug 2012, Accepted 27 Sep 2012, Published online: 01 Nov 2012

References

  • Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363:2424–2433.
  • Yamashita Y, Yuan J, Suetake I, et al. Array-based genomic resequencing of human leukemia. Oncogene 2010; 29:3723–3731.
  • Patel JP, Gonen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366:1078–3731.
  • Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 2011; 43:309–3731.
  • Renneville A, Boissel N, Nibourel O, et al. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia 2012; 26:1247–3731.
  • Hou HA, Kuo YY, Liu CY, et al. DNMT3A mutations in acute myeloid leukemia-stability during disease evolution and the clinical implication. Blood 2012; 119:559–3731.
  • Shen Y, Zhu YM, Fan X, et al. Gene mutation patterns and their prognostic impact in a cohort of1185 patients with acute myeloid leukemia. Blood 2011; 118:5593–3731.
  • Larochelle O, Bertoli S, Vergez F, et al. Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience. Oncotarget 2011; 2:850–861.
  • Metzeler KH, Walker A, Geyer S, et al. DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia. Leukemia 2012; 26:1106–3731.
  • Horne G, Brewin J, Chevassut T. Genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366:2321; author reply 2321–2322.
  • Ribeiro AF, Pratcorona M, Erpelinck-Verschueren C, et al. Mutant DNMT3A: a new marker of poor prognosis in acute myeloid leukemia. Blood 2012 June 14. [Epub ahead of print]
  • Thol F, Damm F, Lüdeking A, et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol 2011; 29:2889–3731.
  • Singh RR, Bains A, Patel KP, et al. Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high resolution melting curve analysis. J Mol Diagn 2012; 14:336–3731.
  • Marcucci G, Metzeler KH, Schwind S, et al. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J Clin Oncol 2012; 30:742–3731.
  • Tiacci E, Spanhol-Rosseto A, Martelli MP, et al. The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. Leukemia 2012; 26:554–3731.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.